Wolverine Asset Management’s Cartesian Growth Corp II RENE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
– Sell
-255,240
Closed -$3.03M – 1771
2025
Q1
$3.03M Sell
255,240
-2,014
-0.8% -$23.7K 0.04% 409
2024
Q4
$3M Sell
257,254
-157,767
-38% -$1.83M 0.03% 422
2024
Q3
$4.76M Sell
415,021
-5,802
-1% -$66K 0.05% 306
2024
Q2
$4.74M Buy
420,823
+58,469
+16% +$656K 0.05% 303
2024
Q1
$4.03M Sell
362,354
-101,817
-22% -$1.12M 0.05% 330
2023
Q4
$5.08M Buy
464,171
+104,768
+29% +$1.14M 0.04% 349
2023
Q3
$3.88M Buy
+359,403
New +$3.86M 0.04% 381
2023
Q2
– Sell
-41,111
Closed -$431K – 1915
2023
Q1
$431K Sell
41,111
-26,202
-39% -$272K 0.01% 892
2022
Q4
$690K Buy
+67,313
New +$683K 0.01% 854

Other funds holding RENE

Wolverine Asset Management's RENE Position: Q2 2025 in Review

Wolverine Asset Management sold out of Cartesian Growth Corp II (RENE) in Q2 2025, closing a stake of 255,240 shares — an estimated $3.03M sold.

Wolverine Asset Management first reported a position in RENE in Q4 2022 and held it in 9 quarters. The position peaked at $5.08M in Q4 2023. 4 funds tracked by Wall St. Rank hold RENE as of Q2 2025.

  • Wolverine Asset Management reported no remaining Cartesian Growth Corp II position as of Q2 2025 after selling out during the quarter.
  • Wolverine Asset Management sold 255,240 Cartesian Growth Corp II shares in Q2 2025, an estimated $3.03M.
  • Wolverine Asset Management first reported a position in Cartesian Growth Corp II in Q4 2022 and held it in 9 quarters.
  • Wolverine Asset Management's Cartesian Growth Corp II position peaked at $5.08M in Q4 2023.
  • 4 funds tracked by Wall St. Rank held Cartesian Growth Corp II as of Q2 2025.

Based on Wolverine Asset Management's 13F filing for Q2 2025, filed 4 Aug 2025.